Myovant Sciences Ltd |
Date/Time | / |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | - |
Previous Close | - |
High | - |
Low | - |
Volume [USD] | - |
Volume [Units] | |
Price fixings | |
ISIN | BMG637AM1024 |
Security | MYOV |
Exchange | NYSE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NYSE | 18.22 | ![]() |
328,225 |
IEX | 18.28 | ![]() |
18,286 |
Cboe US | 18.18 | ![]() |
16,866 |
TradeGate | 17.90 | ![]() |
725 |
gettex | 17.850 | ![]() |
34 |
Frankfurt | 17.6000 | ![]() |
0 |
Berlin | 17.935 | ![]() |
0 |
München | 17.595 | ![]() |
0 |
Stuttgart | 17.595 | ![]() |
News
- Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatment of Advanced Prostate Cancer
02/25/2022 / 15:00 - GlobeNewswire - Myovant Sciences to Present at Upcoming Investor Conferences
02/07/2022 / 14:30 - GlobeNewswire - The Fibroid Foundation Announces Fibroid Summit 2022 - a Patient-Hosted Research Conference
02/01/2022 / 16:30 - GlobeNewswire - Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Updates
01/26/2022 / 12:55 - GlobeNewswire - Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021
01/10/2022 / 12:55 - GlobeNewswire